The European Union Clinical Trial Regulation (EU CTR) is the largest change in the EU clinical trial landscape in 20 years. This year marks the beginning of a three-year transition period during which companies need to implement updated processes and assess systems to enable compliance and effective Clinical Trials Information System (CTIS) interfacing. Companies wanting to run future interventional medicinal trials in the EU now more than ever need to ensure their readiness programs are prioritized.
In this webinar, you will:
1. UNDERSTAND the significant changes the new EU CTR with bring to how clinical trials are conducted in the EU.
2. DISCUSS how companies can adapt their processes and systems to these new systems in order to comply.
3. LEARN which innovative process and technology solutions can help them achieve readiness success.